Feedback / Questions
AB248 - Asher Biotherap
https://www.businesswire.com/news/home/20220408005072/en/Asher-Bio-to-Present-New-Preclinical-Data-Demonstrating-Differentiated-Profile-of-AB248-its-Lead-Cis-targeted-IL-2-Immunotherapy-at-AACR-Annual-Meeting
Apr 8, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next